View |
|
DR-XY20694
|
Cloxacillin (As Sodium)
|
Solaze
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
18 February 2021
|
18 December 2025
|
View |
|
DR-XY20695-B
|
Ofloxacin
|
Floxagen
|
200 mg
|
Tablet
|
Antibacterial (Fluoroquinolone)
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
06 March 2022
|
30 May 2027
|
View |
|
DR-XY20700
|
Ambroxol Hydrochloride
|
Medibron
|
See Annex C
|
Syrup
|
Mucolytic
|
Medi-Rx ,Inc.
|
Philippines
|
Automatic Renewal
|
12 January 2022
|
18 December 2027
|
View |
|
DR-XY20703
|
Cefalexin (As Monohydrate)
|
Sorlex
|
100 mg / mL
|
Powder For Suspension (Oral Drops)
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
06 December 2019
|
07 December 2024
|
View |
|
DR-XY20729
|
Ampicillin (as Sodium)
|
Vatacil
|
250 mg
|
Powder for Injection
|
-
|
YSS Laboratories Compnay Inc.
|
Philippines
|
-
|
14 September 2020
|
03 January 2026
|
View |
|
DR-XY20730
|
Ampicillin (as Sodium)
|
Vatacil
|
500 mg
|
Powder for Injection
|
-
|
YSS Laboratories Compnay Inc.
|
Philippines
|
-
|
14 September 2020
|
03 January 2026
|
View |
|
DR-XY20789-B
|
Aluminum Hydroxide + Magnesium Hydroxide
|
Monnax
|
225 mg/200 mg per 5 mL
|
Suspension
|
Antacid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 August 2022
|
22 September 2027
|
View |
|
DR-XY20801
|
Leuprorelin Acetate
|
Luprolex
|
1.88mg
|
Powder For Injection (Im/Sc)
Sustained Release
|
-
|
Takeda Pharmaceutical Co. Ltd.
|
Japan
|
-
|
29 December 2020
|
19 January 2026
|
View |
|
DR-XY20802
|
Bromhexine Hydrochloride
|
Sherine
|
4 mg/5 mL
|
Syrup
|
Mucolytic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Correction)
|
27 February 2024
|
10 January 2026
|
View |
|
DR-XY20830-B
|
Salbutamol (as Sulfate)
|
Primesal
|
2 mg/5 mL
|
Syrup
|
Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
01 July 2022
|
01 July 2027
|
View |
|
DR-XY20868
|
GUAIFENESIN
|
None
|
100mg/ 5mL
|
Syrup
|
Expectorant
|
FORTIS MEDI PHARMACEUTICAL, INC.
|
China
|
Automatic Renewal
|
04 August 2022
|
03 November 2027
|
View |
|
DR-XY20944
|
Sumatriptan
|
Imigran
|
50 mg
|
Tablet
|
Antimigraine Preparations (Selective serotonin (5HT1) agonists)
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
Renewal
|
04 August 2023
|
16 July 2028
|
View |
|
DR-XY20954
|
MEFENAMIC ACID
|
None
|
250mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
FORTIS MEDI PHARMACEUTICAL, INC.
|
China
|
Automatic Renewal
|
22 September 2022
|
03 November 2027
|
View |
|
DR-XY20961-B
|
Salbutamol (As Sulfate)
|
Salbuvan
|
2 mg
|
Tablet
|
Selective Beta -2-Adrenoreceptor Agonist
|
Philmed Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 September 2022
|
02 September 2027
|
View |
|
DR-XY20973
|
Sodium Choride 0.65% Buffered Solution Nasal Spray
|
Salinase
|
0.0065
|
Nasal Spray
|
IRRIGATING SOLUTIONS
|
El Laboratories, Inc
|
Philippines
|
Automatic Renewal
|
05 October 2022
|
22 November 2026
|
View |
|
DR-XY20977
|
Lamotrigine
|
Lamictal
|
5 mg
|
Dispersible/Chewable Tablet
|
-
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
-
|
26 September 2019
|
22 September 2024
|
View |
|
DR-XY20983
|
Lamotrigine
|
Lamictal
|
25 mg
|
Dispersible/Chewable Tablet
|
Antiepileptic
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
Automatic Renewal
|
29 October 2022
|
11 December 2027
|
View |
|
DR-XY20985
|
Cefalexin (as monohydrate)
|
LEWIMYCIN
|
250mg/5mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
NEW MYREX LABORATORIES INC.
|
Philippines
|
Automatic Renewal
|
30 December 2021
|
19 February 2027
|
View |
|
DR-XY21052
|
Salbutamol (As Sulfate)
|
Beisol
|
2 mg
|
Tablet
|
-
|
Pharmatechnica Laboratory, Inc
|
Philippines
|
Automatic Renewal
|
07 December 2017
|
06 March 2027
|
View |
|
DR-XY21057
|
Cefalexin (As Monohydrate)
|
Cendalex
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
20 May 2022
|
11 July 2027
|